Clinical Trial: A Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental Vitiligo

U.S., Nov. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07251595) titled 'A Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental Vitiligo' on Nov. 19.

Brief Summary: The study is being conducted to evaluate the efficacy, and safety of SHR0302 tablets as single therapy or in combination with SHR0302 Base gel for patients with non-segmental vitiligo.

Study Start Date: Nov., 2025

Study Type: INTERVENTIONAL

Condition: Non-segmental Vitiligo

Intervention: DRUG: SHR0302 Tablets

SHR0302 tablets.

DRUG: SHR0302 Base Gel

SHR0302 Base gel.

DRUG: SHR0302 Placebo Tablets

SHR0302 placebo tablets.

DRUG: SHR0302 Base Placebo Gel

SHR0302 Base placebo gel.

Recruitment Status: NOT_YET_R...